The week in review


Jo Watson (centre) with fellow review panelists Professor Steven King (l) and Bill Scott.

The King Review has again been the hot topic of the week in pharmacy, with the final consultative forum being held as a live webcast from Canberra on Wednesday.

The webcast, which saw Professor Stephen King state the case for the review and alongside panel members Bill Scott and Jo Watson, answer a variety of pointed questions from attendees on subjects ranging from the status of HMRs and whether pharmacies should be “selling stuff” to who has a seat at the table to negotiate Community Pharmacy Agreements and whether the location rules are best serving the consumer.

The Hepatitis C medicines cost issue also reared its head during the webcast, with panel members agreeing on the listing of these medicines as an enormous success to public health, but also that it has raised issues about supply and cost arrangements.

We got a look at the latest snapshot of medicines usage and revealed a slight drop in pharmacy-based adverse event reports.

The Guild’s Pharmacy Connect conference is underway, opening yesterday with a speech from Professor Henry Ergas backing the status quo when it comes to the ownership and location rules.

Reader Andrew cheekily summed this up as, “Economist paid by the Pharmacy Guild backs Guild position”.

Also at Pharmacy Connect we saw Emma McBride, Labor MP for Dobell in northern NSW, tell the conference that “protecting and enhancing the PBS… is one of my key priorities as a member of Parliament”.

One of our top-rating articles this week was by Capital Chemist Wanniassa partner Elise Apolloni, who let us in on her secret to great interns: great preceptors.

And talking of great women in pharmacy, don’t forget to cast your vote in our 10 Women of Influence poll! Readers can vote for as many outstanding female pharmacists as they want.

 

Previous Poll: how should CPAs be negotiated?
Next Pharmacy wages under fire

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.

No Comment

Leave a reply